-
Mashup Score: 5AACE Advocacy Training Program - 3 day(s) ago
Register for our FREE virtual AACE Advocacy Training Program, designed to empower endocrinologists, endocrine care team members, industry professionals, and patient advocates with the knowledge, strategies, and tools to become an effective advocate for endocrine issues such as improved access to endocrine care.
Source: pro.aace.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 6Episode 55: Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia - 3 day(s) ago
In this episode, Dr. Vin Tangpricha and Dr. Rifka Schulman-Rosenbaum discuss strategies for managing inpatient hyperglycemia, the risks of SGLT-2 inhibitors in hospitalized patients, and identifying good candidates for safer alternatives, such as DPP-4 inhibitors and insulin.
Source: pro.aace.comCategories: General Medicine News, EndocrinologyTweet-
🎧 Tune in to our latest podcast with endocrine experts @vtangpricha and @RifkaSchulmanMD as they explore the complexities of managing inpatient hyperglycemia. This discussion is essential for optimizing hospital-based diabetes care: https://t.co/2d8XWkhqAw #endocrinology
-
-
Mashup Score: 3| AACE Annual Meeting 2025 - 3 day(s) ago
The program theme: Endocrine Innovation & Obesity Breakthroughs will dive into groundbreaking approaches to metabolic disorders and obesity. Leading experts will share insights on the latest advancements in endocrine health, offering real-world solutions to improve outcomes and equity in the fight against obesity. Science is at the center of what we do, and #AACE25 is the place to be for the newest information affecting endocrinology. Catch up with old friends and meet new ones by registering today!
Source: am.aace.comCategories: General Medicine News, EndocrinologyTweet-
Registration and housing are open for the AACE Annual Meeting happening May 15-17, 2025, in Orlando, FL. Register now and save with early bird rates: https://t.co/q13GRNjta0 #AACE2025 #endocrinology https://t.co/hwP5syRM7E
-
-
Mashup Score: 1
During intensive hematologic care, patients are exposed to high-dose chemotherapy, corticosteroids, immunosuppressants, and total parenteral nutrition. Combined with physiologic stress and increased release of cytokines and hormones, this can lead to dysglycemia, which is associated with adverse clinical outcomes. This prospective study aimed to investigate continuous glucose monitoring (CGM) to identify dysglycemia during intensive hematologic care.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet-
Results suggest a need for further studies into CGM as method to optimize glucose levels, which could improve outcomes in patients receiving intensive hematologic care. Read more: https://t.co/jeRc2nkbf4 #EndocrinePractice #endocrinology @vtangpricha @Els_ENDO https://t.co/9GlfdHMUZa
-
-
Mashup Score: 2| AACE Annual Meeting 2025 - 4 day(s) ago
The program theme: Endocrine Innovation & Obesity Breakthroughs will dive into groundbreaking approaches to metabolic disorders and obesity. Leading experts will share insights on the latest advancements in endocrine health, offering real-world solutions to improve outcomes and equity in the fight against obesity. Science is at the center of what we do, and #AACE25 is the place to be for the newest information affecting endocrinology. Catch up with old friends and meet new ones by registering today!
Source: am.aace.comCategories: General Medicine News, EndocrinologyTweet-
Registration and housing are open for the AACE Annual Meeting happening May 15-17, 2025, in Orlando, FL. Register now and save with early bird rates: https://t.co/q13GRNjta0 #AACE2025 #endocrinology https://t.co/hwP5syRM7E
-
-
Mashup Score: 2Association Between Parathyroid Hormone-Related Peptide Levels and Mortality in Patients With Malignancy - 4 day(s) ago
Hypercalcemia of malignancy is a risk factor for mortality in patients with malignancies. Although the parathyroid hormone-related protein (PTHrP) secreted by tumor cells induces hypercalcemia, the association between serum PTHrP levels and mortality remains unclear. This study aimed to investigate the association between serum PTHrP levels and mortality in patients with malignancies.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet-
This study showed an association between PTHrP and mortality in patients with malignancy after adjusting for serum calcium levels. Read more: https://t.co/C1tYAVTEPJ #EndocrinePractice #endocrinology @vtangpricha @Els_ENDO
-
-
Mashup Score: 7Nephrotic Syndrome as a Complication of Systemic Calcitonin Amyloidosis From Long-Standing Metastatic Medullary Thyroid Cancer - 5 day(s) ago
Medullary thyroid cancer often results in elevated calcitonin levels, which can cause localized formation of calcitonin amyloid, though rarely complications of systemic calcitonin amyloidosis have been reported. The objective of this report is to encourage awareness of calcitonin amyloid causing nephrotic syndrome in patients with metastatic medullary thyroid cancer.
Source: www.aaceclinicalcasereports.comCategories: General Medicine News, EndocrinologyTweet-
This case contributes to a small body of evidence that metastatic MTC can also result in systemic calcitonin amyloidosis and resulting complications, including nephrotic syndrome. Read more: https://t.co/gOwxsjJCTs @Els_ENDO @sina_jasim #endocrinology
-
-
Mashup Score: 3
Cushing’s syndrome is a condition caused by prolonged exposure to high levels of a stress hormone, cortisol (glucocorticoid hormones). Learn more about Cushing’s syndrome, its signs and symptoms, screening, diagnosis, treatment, and how to actively participate in managing your health through shared decision-making with your health care professional.
Source: www.aace.comCategories: General Medicine News, EndocrinologyTweet-
Now Available: The AACE Patient Guide to Rare Endocrine Diseases: Cushing's Syndrome offers easy to understand evidence-based information on symptoms, treatment options, and lifestyle changes. Share this new resource with your patients today: https://t.co/Q2CEWKistm… https://t.co/6acHAcf2bi https://t.co/VnDl5sS9Iz
-
-
Mashup Score: 0
This initiative is designed to help primary care clinicians establish practice-level strategies for enhancing patient-centered care of diabetes with diabetes technology.  The educational strategies learned through this program will address the opportunities for implementation in practices of various sizes and resources.   Starts 5/31/2024 | Expires 5/31/2025
Source: pro.aace.comCategories: General Medicine News, EndocrinologyTweet-
Register for this free course! Examine various approaches to implementing #diabetes technologies & identify resources to help patients use their devices. Register today: https://t.co/L9QxR6jxGi #endotwitter
-
-
Mashup Score: 7Unmasking a Rare Genetic Mutation: The Importance of Genetic Testing in Refractory Hypertriglyceridemia - 6 day(s) ago
Genetic causes of hypertriglyceridemia like familial chylomicronemia syndrome can be overlooked in everyday practice. We report a patient with a rare genetic mutation, highlighting the importance of genetic testing for timely diagnosis and prevention of complications.
Source: www.aaceclinicalcasereports.comCategories: General Medicine News, EndocrinologyTweet-
In an outpatient endocrine setting, genetic mutations should not be underestimated in cases of refractory hypertriglyceridemia. Read more: https://t.co/gWvLns48Du @sina_jasim @Els_ENDO #endocrinology
-
Are you passionate about improving endocrine healthcare and advocating for better patient outcomes? Join us on Oct. 18 for the AACE Advocacy Training Program, a FREE virtual event! Learn more: https://t.co/3mXbQhH0Rj #endotwitter #endocrinology